Century Therapeutics is dedicated to revolutionizing the treatment landscape for cancer and autoimmune diseases through pioneering allogeneic, iPSC-derived NK and T cell therapies. The company focuses on developing innovative therapies that are not only more effective but also more tolerable, accessible, and affordable compared to existing cell therapies. By harnessing the limitless self-renewing abilities of induced pluripotent stem cells (iPSC) alongside advanced cellular engineering and manufacturing technologies, Century Therapeutics aims to create tailored solutions designed specifically to address the limitations found in current treatments.

Their robust pipeline showcases a strategic prioritization of four potentially transformative preclinical programs, underscoring their commitment to advancing cutting-edge therapeutics to the clinic. With a vision characterized by precision design and enduring impact, Century Therapeutics is poised to make a significant contribution to improving patient outcomes in oncology and immunology. For those interested in their clinical developments or business opportunities, Century Therapeutics provides accessible resources and clear channels for outreach.